Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Peter Vasili Kharchenko, Ph.D.

Co-Author

This page shows the publications co-authored by Peter Kharchenko and Mitzi Kuroda.
Connection Strength

1.470
  1. BioTAP-XL: Cross-linking/Tandem Affinity Purification to Study DNA Targets, RNA, and Protein Components of Chromatin-Associated Complexes. Curr Protoc Mol Biol. 2015 Jan 05; 109:21.30.1-21.30.32.
    View in: PubMed
    Score: 0.151
  2. Heterochromatin-associated interactions of Drosophila HP1a with dADD1, HIPP1, and repetitive RNAs. Genes Dev. 2014 Jul 01; 28(13):1445-60.
    View in: PubMed
    Score: 0.145
  3. Reciprocal interactions of human C10orf12 and C17orf96 with PRC2 revealed by BioTAP-XL cross-linking and affinity purification. Proc Natl Acad Sci U S A. 2014 Feb 18; 111(7):2488-93.
    View in: PubMed
    Score: 0.141
  4. "Jump start and gain" model for dosage compensation in Drosophila based on direct sequencing of nascent transcripts. Cell Rep. 2013 Nov 14; 5(3):629-36.
    View in: PubMed
    Score: 0.139
  5. Chromatin proteins captured by ChIP-mass spectrometry are linked to dosage compensation in Drosophila. Nat Struct Mol Biol. 2013 Feb; 20(2):202-9.
    View in: PubMed
    Score: 0.131
  6. X chromosome dosage compensation via enhanced transcriptional elongation in Drosophila. Nature. 2011 Mar 03; 471(7336):115-8.
    View in: PubMed
    Score: 0.115
  7. Comprehensive analysis of the chromatin landscape in Drosophila melanogaster. Nature. 2011 Mar 24; 471(7339):480-5.
    View in: PubMed
    Score: 0.114
  8. Long-range spreading of dosage compensation in Drosophila captures transcribed autosomal genes inserted on X. Genes Dev. 2009 Oct 01; 23(19):2266-71.
    View in: PubMed
    Score: 0.105
  9. A sequence motif within chromatin entry sites directs MSL establishment on the Drosophila X chromosome. Cell. 2008 Aug 22; 134(4):599-609.
    View in: PubMed
    Score: 0.097
  10. Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma. Proc Natl Acad Sci U S A. 2017 05 23; 114(21):E4184-E4192.
    View in: PubMed
    Score: 0.044
  11. The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains. Genes Dev. 2015 Jul 15; 29(14):1507-23.
    View in: PubMed
    Score: 0.039
  12. Comparative analysis of metazoan chromatin organization. Nature. 2014 Aug 28; 512(7515):449-52.
    View in: PubMed
    Score: 0.037
  13. Enrichment of HP1a on Drosophila chromosome 4 genes creates an alternate chromatin structure critical for regulation in this heterochromatic domain. PLoS Genet. 2012 Sep; 8(9):e1002954.
    View in: PubMed
    Score: 0.032
  14. Nature and function of insulator protein binding sites in the Drosophila genome. Genome Res. 2012 Nov; 22(11):2188-98.
    View in: PubMed
    Score: 0.032
  15. Sequence-specific targeting of dosage compensation in Drosophila favors an active chromatin context. PLoS Genet. 2012; 8(4):e1002646.
    View in: PubMed
    Score: 0.031
  16. The genomic binding sites of a noncoding RNA. Proc Natl Acad Sci U S A. 2011 Dec 20; 108(51):20497-502.
    View in: PubMed
    Score: 0.030
  17. Plasticity in patterns of histone modifications and chromosomal proteins in Drosophila heterochromatin. Genome Res. 2011 Feb; 21(2):147-63.
    View in: PubMed
    Score: 0.028
  18. Identification of functional elements and regulatory circuits by Drosophila modENCODE. Science. 2010 Dec 24; 330(6012):1787-97.
    View in: PubMed
    Score: 0.028
  19. An assessment of histone-modification antibody quality. Nat Struct Mol Biol. 2011 Jan; 18(1):91-3.
    View in: PubMed
    Score: 0.028
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.